AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 187 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $7,441 | +6.3% | 265 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $7,000 | +16.7% | 265 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $6,000 | -25.0% | 265 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $8,000 | -11.1% | 265 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $9,000 | -25.0% | 265 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $12,000 | -20.0% | 265 | 0.0% | 0.01% | -14.3% |
| Q2 2021 | $15,000 | +7.1% | 265 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $14,000 | +27.3% | 265 | 0.0% | 0.01% | +16.7% |
| Q4 2020 | $11,000 | +22.2% | 265 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $9,000 | -35.7% | 265 | 0.0% | 0.01% | -40.0% |
| Q2 2020 | $14,000 | +55.6% | 265 | 0.0% | 0.01% | +25.0% |
| Q1 2020 | $9,000 | -30.8% | 265 | 0.0% | 0.01% | -11.1% |
| Q4 2019 | $13,000 | +44.4% | 265 | 0.0% | 0.01% | +28.6% |
| Q3 2019 | $9,000 | -30.8% | 265 | 0.0% | 0.01% | -36.4% |
| Q2 2019 | $13,000 | -27.8% | 265 | 0.0% | 0.01% | -31.2% |
| Q1 2019 | $18,000 | +50.0% | 265 | 0.0% | 0.02% | +33.3% |
| Q4 2018 | $12,000 | – | 265 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
| Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
| Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
| Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
| Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
| Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
| COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
| Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
| CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |